← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Biocorrx, Inc.
Anaheim, CA
$9,227,066
Total funding
2
Grants
Funding over time
peak $3.5M · FY2019–22$5M$3.8M$2.5M$1.3M$0
'19
'20
'21
'22
Funding mix
By agency
NIH$9,227,066 · 2
By mechanism
UG3$5,674,268 · 1
UH3$3,552,798 · 1
Investigators at Biocorrx, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Not enough data
Largest grants
Development of a 3-month implantable depot pellet of Naltrexone for the treatment of Opioid Use Disorder.$3,453,367
UH3 · FY2021 · DA
Development of a 3-month implantable depot pellet of Naltrexone for the treatment of Opioid Use Disorder.$2,842,430
UG3 · FY2019 · DA
Development of a 3-month implantable depot pellet of Naltrexone for the treatment of Opioid Use Disorder.$2,831,838
UG3 · FY2020 · DA
Development of a 3-month implantable depot pellet of Naltrexone for the treatment of Opioid Use Disorder.$99,431
UH3 · FY2022 · DA